Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: experienced (1000), adept (3), accomplished (7), trained (492), expert (202)

Alectinib

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) ALECTINIB Regimen • NSCLC - ALECtinib Indication • Alectinib (as monotherapy) is indicated for first-line
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Alectinib.pdf

Cisplatin (70) Gemcitabine ver1.1

Description: Chemotherapy Protocol BLADDER CISPLATIN (70)-GEMCITABINE Regimen Bladder-Cisplatin (70)-Gemcitabine Indication First line treatment of locally advanced or metastatic urothelial
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Cisplatin-70-Gemcitabine-ver1.1.pdf

Cisplatin (35) Gemcitabine ver1.1

Description: Chemotherapy Protocol BLADDER CISPLATIN (35)-GEMCITABINE Regimen Bladder-Cisplatin (35)-Gemcitabine Indication For use in patients unable to tolerate standard cisplatin
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Cisplatin-35-Gemcitabine-ver1.1.pdf

Tivozanib

Description: Chemotherapy Protocol RENAL CELL Regimen TIVOZANIB • Renal Cell - Tivozanib Indication • Patients with a confirmed histological diagnosis of renal cell carcinoma with
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Tivozanib.pdf

Sunitinib v1.1

Description: Regimen Renal Cell - Sunitinib Indication Chemotherapy Protocol RENAL CELL SUNITINIB First line treatment of advanced or metastatic renal cell carcinoma WHO
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Sunitinib-v1.1.pdf

Pazopanib v1.1

Description: Chemotherapy Protocol RENAL CELL PAZOPANIB Regimen Renal Cell - Pazopanib Indication First line treatment option for people with advanced renal cell carcinoma
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Pazopanib-v1.1.pdf

Cabozantinib

Description: Chemotherapy Protocol RENAL CELL CANCER Regimen CABOZANTINIB • Renal Cell – Cabozantinib (60mg-tablets) Indication • Cabozantinib s indicated for the treatment of advanced
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Cabozantinib.pdf

Axitinib v1.2

Description: Chemotherapy Protocol RENAL CELL AXITINIB This regimen may require funding Regimen Renal Cell - Axitinib Indication Second line treatment of advanced or
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Axitinib-v1.2.pdf

Obinutuzumab_maintenance

Description: Chemotherapy Protocol Non-Hodgkin Lymphoma Obinutuzumab (Maintenance) Regimen • NHL – Obinutuzumab (Maintenance) Indication • Obinutuzumab in combination with bendamustine followed by obinutuzumab maintenance
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Obinutuzumab-maintenance.pdf

InP cytarabine methotrexate

Description: Chemotherapy Protocol LYMPHOMA CYTARABINE-METHOTREXATE Inpatient Regimen Regimen • Lymphoma – InP-Cytarabine-Methotrexate Indication • Non-Hodgkin’s Lymphoma (CNS disease) Toxicity Drug
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-cytarabine-methotrexate.pdf

471 to 480 of 614

Previous … 46 47 48 49 50 … Next